TCM Biotech International Corp. (TPE:4169)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
149.00
+0.50 (0.34%)
Aug 19, 2026, 1:30 PM CST

TCM Biotech International Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
701.63685.49666.53969.62802.42702.05
Revenue Growth
4.03%2.84%-31.26%20.84%14.30%-4.75%
Gross Profit
317.87316.99327.31480.17448.49358.72
Operating Income
-38.7318.6510.722.3325.32.13
Net Income
-31.519.1721.0118.5718.271.87
Earnings Per Share
-0.520.320.360.350.370.04
EPS Growth
--10.06%1.66%-5.41%861.49%-92.66%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Department Medicine
627.77609.04905.78721.03637.09
Functional Food
57.6156.8863.3562.3764.96
Other Department
0.110.620.4919.02-
Total
685.49666.53969.62802.42702.05

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,197545.07532.98504.1389.9458.26
Total Debt
16.5537.243.46115.38157.46161
Net Cash (Debt)
1,180507.87489.52388.76-67.52-102.75
Net Cash Growth
141.49%3.75%25.92%---
Net Cash Per Share
19.248.608.297.33-1.38-2.11

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.7837.13167.42-37.5452.2415.33
Capital Expenditures
-2.43-2.49-8-3.98-3.78-4.14
Free Cash Flow
-12.2134.65159.42-41.5148.4611.19
Free Cash Flow Growth
--78.27%--333.15%-84.45%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.30%46.24%49.11%49.52%55.89%51.10%
Operating Margin
-5.52%2.72%1.60%2.30%3.15%0.30%
Pretax Margin
-4.38%3.25%3.75%2.27%2.88%0.32%
Profit Margin
-4.49%2.80%3.15%1.92%2.28%0.27%
FCF Margin
-1.74%5.05%23.92%-4.28%6.04%1.59%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.3600.3600.3500.2850.033
Dividend Per Share Growth
-8.57%2.86%22.81%763.64%-
Dividend Yield
0.24%0.21%0.61%0.50%0.11%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-532.89162.73185.0282.21970.95
Forward PE
111.2489.6342.5799.49--
P/FCF Ratio
-294.8621.45-30.98162.55
PS Ratio
12.5014.905.133.541.872.59